Caricamento...

Optimal Monitoring of Weekly IGF-I Levels During Growth Hormone Therapy With Once-Weekly Somapacitan

CONTEXT: Somapacitan is a long-acting growth hormone (GH) in development for once-weekly treatment of GH deficiency (GHD). Optimal monitoring of insulin-like growth factor-I (IGF-I) levels must account for weekly IGF-I fluctuations following somapacitan administration. OBJECTIVE: To develop and asse...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Endocrinol Metab
Autori principali: Juul Kildemoes, Rasmus, Højby Rasmussen, Michael, Agersø, Henrik, Overgaard, Rune Viig
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7823237/
https://ncbi.nlm.nih.gov/pubmed/33313798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa775
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !